another example of roche marketing superiority vs gsk inept response to all the market opportunities to increase relenza market share. bta management should take note and notify their their solicitors to add this loss to our claim.
i wish bta management is much more proactive.
another example of roche marketing superiority vs gsk inept...
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)